Successful Use of Levosimendan in a Patient with Peripartum Cardiomyopathy
- 1 March 2004
- journal article
- case report
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 98 (3) , 822-824
- https://doi.org/10.1213/01.ane.0000099717.40471.83
Abstract
This case represents the first reported use of levosimendan, a calcium-sensitizing drug with additional vasodilation properties, for treatment of a woman with peripartum cardiomyopathy. Levosimendan induced a steady decline of increased pulmonary capillary wedge pressure, followed by a definitive increase in cardiac stroke volume. The patient recovered from this serious episode of heart failure, and she ultimately regained left ventricular function.Keywords
This publication has 13 references indexed in Scilit:
- Peripartum cardiomyopathy: a condition intensivists should be aware ofIntensive Care Medicine, 2003
- Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN)European Heart Journal, 2002
- Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trialThe Lancet, 2002
- Amniotic fluid embolus: a review of the literatureCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2001
- Acute Hemodynamic and Clinical Effects of Levosimendan in Patients With Severe Heart FailureCirculation, 2000
- Peripartum CardiomyopathyJAMA, 2000
- Focus on Primary CareObstetrical & Gynecological Survey, 1999
- Maternal Respiratory Arrests, Severe Hypotension, and Fetal Distress after Administration of Intrathecal, Sufentanil, and Bupivacaine after Intravenous FentanylAnesthesiology, 1997
- Peripartum cardiomyopathyAmerican Heart Journal, 1995
- Peripartum Cardiomyopathy Presenting at Cesarean DeliveryAnesthesiology, 1985